{{Rsnum
|rsid=5393
|Gene=SLC2A2
|Chromosome=3
|position=171027131
|Orientation=minus
|GMAF=0.1956
|Gene_s=SLC2A2
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;C)
|geno3=(C;C)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;C)
| geno3=(C;C)
| CEU | 77.9 | 18.6 | 3.5
| HCB | 91.9 | 8.1 | 0.0
| JPT | 91.2 | 8.8 | 0.0
| YRI | 25.3 | 53.4 | 21.2
| ASW | 37.5 | 46.4 | 16.1
| CHB | 91.9 | 8.1 | 0.0
| CHD | 88.1 | 10.1 | 1.8
| GIH | 66.0 | 27.0 | 7.0
| LWK | 18.7 | 53.3 | 28.0
| MEX | 66.1 | 30.4 | 3.6
| MKK | 37.2 | 47.4 | 15.4
| TSI | 72.3 | 22.8 | 5.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=21673421
|Title=Genetic factors in risk assessment for the development of type 2 diabetes mellitus in a small case series
}}

{{PMID Auto
|PMID=15983230
|Title=Polymorphisms in the SLC2A2 (GLUT2) gene are associated with the conversion from impaired glucose tolerance to type 2 diabetes: the Finnish Diabetes Prevention Study.
}}

{{PMID Auto
|PMID=17636114
|Title=Physical activity modifies the effect of SNPs in the SLC2A2 (GLUT2) and ABCC8 (SUR1) genes on the risk of developing type 2 diabetes.
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}